Lung cancer Posts - Page 41 of 52 on Medivizor
Navigation Menu

Lung cancer Posts on Medivizor

Benefits of collaborative team care at different stages of non-small cell lung cancer

Benefits of collaborative team care at different stages of non-small cell lung cancer

Posted by on May 29, 2015 in Lung cancer | 0 comments

In a nutshell The authors aimed to assess whether collaboration of different healthcare professionals can help treat non-small cell lung cancer (NSCLC) patients better and improve overall survival. Some background Treatment of NSCLC is decided based on the stage of the cancer. In the early stage (I/II), surgery and chemotherapy are the...

Read More

Erlotinib with pemetrexed and cisplatin for lung cancer that has spread to the brain

Erlotinib with pemetrexed and cisplatin for lung cancer that has spread to the brain

Posted by on May 19, 2015 in Lung cancer | 0 comments

In a nutshell The objective of this study was to evaluate the effect of erlotinib (Tarceva) in combination with pemetrexed (Alimta) and cisplatin (Platinol) in lung cancer that had spread into the brain (brain metastases). Some background Lung adenocarcinoma is the cancer of glandular cells of lungs. It is a common type of non-small cell lung...

Read More

Racotumomab vaccine : a maintenance therapy in advanced non-small cell lung cancer

Racotumomab vaccine : a maintenance therapy in advanced non-small cell lung cancer

Posted by on May 12, 2015 in Lung cancer | 0 comments

In a nutshell The objective of this research was to analyze the safety and effectiveness of racotumomab (Vaxira) vaccine in advanced non-small cell lung cancer (NSCLC). Some background In the advanced stage (IIB/ IV) of NSCLC, cancer may spread throughout lungs, to adjacent lymph nodes (tiny, bean-shaped organs that help fight infections) and to...

Read More

Can we estimate the benefit of vandetanib and docetaxel in advanced non-small cell lung cancer?

Can we estimate the benefit of vandetanib and  docetaxel in advanced non-small cell lung cancer?

Posted by on May 12, 2015 in Lung cancer | 0 comments

In a nutshell The aim of this study was to determine whether the benefit from combination therapy of vandetanib (Caprelsa) and docetaxel (Taxotere) could be linked to specific biological substances in non-small cell lung cancer (NSCLC) patients. Some background In advanced stage (IIB/IV) NSCLC, cancer may spread throughout lungs and to other...

Read More

Linifanib with carboplatin and paclitaxel in nonsquamous non-small cell lung cancer

Posted by on May 11, 2015 in Lung cancer | 0 comments

In a nutshell The objective of this study was to determine whether addition of  linifanib to a combination of carboplatin (Paraplatin) and paclitaxel (Taxol) could benefit advanced nonsquamous non-small cell lung cancer (NSCLC) patients. Some background Nonsquamous NSCLC is a type of lung cancer where the cancer starts in cells other than...

Read More

Treatment of small cell lung cancer

Treatment of small cell lung cancer

Posted by on May 11, 2015 in Lung cancer | 0 comments

In a nutshell In this review, the authors explored different options to treat small cell lung cancer (SCLC) and the challenges associated with them. Some background SCLC accounts to 15-20% of all lung cancer. For treatment purposes, SCLC is divided into two stages (phases): limited disease (LD) and extensive disease (ED). In LD, cancer is usually...

Read More

Positive Thinking and Cancer-Myth-Making

Positive Thinking and Cancer-Myth-Making

Posted by on Apr 30, 2015 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 20 comments

Called the “Emperor of All Maladies.” there’s little doubt that a cancer diagnosis throws life completely out of control.  Unfortunately, this chaos creates vulnerabilities that can and have been exploited.  It is tempting to believe the idea that if you control your thoughts and make them positive, you can control cancer. However...

Read More